INS and Hypoglycemia: However, challenges of current insulin therapies, including narrow therapeutic index (TI) to hypoglycemia and body weight gain, limit their adoption and, when adopted, challenge patients’ ability to achieve ideal glycemic control as a consequence of underdosing due to fear of hypoglycemia7,8.